Who we are
Our network is a collaboration between various departments at Oxford University, Oxford Brookes University and Reading University.
To find out more about being part of the Network Centre, contact us at aruk.administrator@dpag.ox.ac.uk / tel: 01865 282358.
Many of our members are also part of the OxDARE research network whose directory can be searched here.
View up to date information about network members here
Oxford ARUK Organising Committee
Current members of the Oxford Network Centre
Neuroscience, Molecular Biology, primary cell culture
Clinical neurology, neuroimaging, cognition
Name |
Affiliation |
|
Members A-C |
||
Nuffield Department of Clinical Neurosciences, University of Oxford |
Cellular and molecular biology |
|
ODDI/Department of Physiology, Anatomy and Genetics, University of Oxford |
Bioinformatics |
|
Nuffield Department of Clinical Neurosciences, University of Oxford |
Cognitive tests, neuropsychology |
|
Department of Pharmacology, University of Oxford |
Cellular and molecular biology | |
Nuffield Department of Clinical Neurosciences, University of Oxford |
Fly genetics, cell-based assays, genomics and neuropathology |
|
Joshua Almond-Thynne* |
Alzheimer's Research UK Oxford Drug Discovery Institute |
|
Department of Psychiatry. University of Oxford |
Blood & CSF analysis, cellular and molecular biology |
|
Nuffield Department of Clinical Neurosciences, University of Oxford |
Molecular neuropathology |
|
Nuffield Department of Clinical Neurosciences, University of Oxford |
Microbiology, cell biology, biotechnology |
|
Department of Psychiatry. University of Oxford |
Blood & CSF analysis, cellular and molecular biology, cohorts, imaging |
|
Department of Psychiatry. University of Oxford |
Molecular Biology, Biostatistics, Bioinformatics |
|
|
Department of Physiology, Anatomy and Genetics, University of Oxford |
Electrophysiology, cellular and molecular biology |
Department of Psychiatry and FMRIB Centre at the University of Oxford |
Fitness training with MRI scanning and cognitive assessment |
|
Department of Pharmacy, University of Reading |
Cellular and molecular biology |
|
Structural Genomics Consortium, University of Oxford |
Structural Genomics Consortium Chief Scientist, Protein Science and Structural Biology |
|
Structural Genomics Consortium, University of Oxford |
Epigenetics, target discovery, parallel organic synthesis |
|
Oxford Institute of Nursing, Midwifery and Allied Health Research (OxINMAHR) Faculty of Health and Life Sciences, Oxford Brookes University |
Reader in Complex Older Persons Care Lead of the International Dementia and Culture Collaborative (IDCC) |
|
Nuffield Department of Clinical Neurosciences, University of Oxford |
Experimental psychology & cognitive neuroscience, electrophysiology (EEG), imaging |
|
|
||
Phillippa Carling |
Department of Physiology, Anatomy and Genetics, University of Oxford |
Cell Biology, Molecular Biology, Neuroscience, target discovery, iPSc |
Anna Cederbalk* |
Alzheimer's Research UK Oxford Drug Discovery Institute |
Target Discovery |
Nuffield Department of Clinical Neurosciences, University of Oxford |
Imaging, neuropathology |
|
Jonathan Cheung* |
Nuffield Department of Clinical Neurosciences, University of Oxford |
|
Nuffield Department of Clinical Neurosciences, University of Oxford |
Clinical research nurse |
|
Department of Sport and Health Sciences, Oxford Brookes |
Lecturer in Nutrition |
|
DeNDRoN / Oxford University Hospitals NHS Trust |
Research delivery manager |
|
James Martin Stem Cell Facility, William Dunn School of Pathology |
Cellular and molecular biology, genetics & genomics |
|
Members D-I |
||
Department of Pharmacy, University of Reading |
Cellular and molecular biology, electrophysiology (EEG), imaging, pharmacology |
|
Nuffield Department of Clinical Neurosciences, University of Oxford |
iPSc, ALS, FTD, phenotypes, drug discovery |
|
Department of Psychiatry. University of Oxford |
iPSc, clusterin, henotypic readout, rodent models |
|
Alzheimer's Research UK Oxford Drug Discovery Institute |
CSO of ARUK Oxford Drug Discovery Institute |
|
Department of Physiology, Anatomy and Genetics, Oxford University |
Alzheimer's taget discovery, neurogenesis |
|
Faculty of Health and Life Sciences at Oxford Brookes University |
Movement, rehabilitation and exercise |
|
Stephane De Cesco |
Target Discovery Institute, Oxford |
Computational chemistry, target discovery |
Nuffield Department of Clinical Neurosciences, University of Oxford |
Cellular and molecular biology, genetics & genomics, neuropathology |
|
Department of Psychiatry, University of Oxford |
MRI, cognitive psychology, exercise, brain structure and function |
|
Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford |
Target validation, drug discovery, iPSc |
|
Sarah Dixon-Clarke |
Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford |
Structural Biology, X-ray crystallography |
Department of Physiology, Anatomy and Genetics, Oxford University |
Parkinson's |
|
Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford |
Biotechnology, molecular biology, structural biology |
|
Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford |
Discovery of chemical probes |
|
Nuffield Department of Clinical Neurosciences, University of Oxford |
Genetics & genomics, neuropathology |
|
Movement Science Group, Oxford Brookes University |
Biomechanics, movement analysis |
|
Structural Genomics Consortium, University of Oxford |
Chemical probe discovery, Epigenetics |
|
Ana Ferreira da Silva* |
Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford |
Cellular and molecular biology |
Department of Psychiatry, University of Oxford |
Epidemiology/ cohort studies, fMRI, MRI |
|
|
||
Sarah Floud | Nuffield Department of Population Health, Oxford University |
Dementia epidemiology |
Evangeline Foster | Department of Psychiatry, University of Oxford |
Clusterin protein, CRISPR/CAS-9, iPSc |
Reading School of Pharmacy |
Cellular and molecular biology |
|
Nuffield Department of Clinical Neurosciences, University of Oxford |
In vivo physiology, behaviour, histology |
|
Mariacarmela Giurrandino |
Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford |
Drug discovery, screening, pharmacology |
Ludovica Griffanti | Nuffield Department of Clinical Neurosciences, University of Oxford | MRI, multi-modal imaging, biomarkers |
Franziska Guenther |
Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford |
Drug discovery |
Anne-Marie Haigh |
Nuffield Department of Clinical Neurosciences, University of Oxford |
Cognitive tests, fMRI, genetics, histopathology, neuropsychology |
Alzheimer's Research UK's Oxford Drug Discovery Institute |
Translational neuroscientis, Cellular biology |
|
Department of Life, Health & Chemical Sciences, Open University |
Transgenic models, cellular and molecular biology, neuropathology |
|
School of Psychology & Clinical Language Sciences, University of Reading |
Nutrition, cognition and healthy ageing |
|
Kate Humphrey |
Department of medicine, Oxford University |
|
Members J-M |
|
|
Catherine Joachim |
Nuffield Department of Clinical Neurosciences, University of Oxford |
|
ARUK Oxford Drug Discovery Institute, University of Oxford |
Protein aggregation, molecular neurobiology, cell culture, prion protein, rna technology |
|
Carole Johnston |
Department of Pharmacology, University of Oxford |
Lab manager |
Keely Jones |
ARUK Oxford Drug Discovery Institute, University of Oxford |
Oxford Drug Discovery Institute Administrator |
Mindaugas Jonikas* |
Department of Physiology, Anatomy and Genetics, University of Oxford |
Cell biology, molecular biology, neuroscience |
Reading School of Pharmacy |
Cell biology, molecular biology, neuroscience |
|
Maria Karabova |
Sir William Dunn School of Pathology, Oxford University |
Neuroinflammation in neurodegeneration |
ARUK Oxford Drug Discovery Institute, University of Oxford |
Histology, neuroscience, physiology |
|
Department of Psychiatry, University of Oxford |
Clinical bioinformatics |
|
Department of Physiology, Anatomy and Genetics, University of Oxford |
Learning & memory |
|
Department of Psychiatry, University of Oxford |
Stochastic analysis, numerical methods for PDE's
Statistical machine learning and data mining
|
|
Department of Psychiatry, University of Oxford |
Biomarkers, psychiatry |
|
Department of Physiology, Anatomy and Genetics, University of Oxford |
Cellular and molecular biology, genetics & genomics |
|
Earth Sciences, Oxford University |
Trace metals - metalloprotein interactions |
|
Department of Psychiatry, University of Oxford |
Phenotyping, biomarkers |
|
Cecilia (Heyne) Lee |
James Martin Stem Cell Facility, Sir William Dunn School of Pathology |
Cellular and molecular biology |
Department of Pharmacology, University of Oxford |
Genetic epidemiology |
|
Ethlyn Lloyd-Morris |
Department of Physiology, Anatomy and Genetics, University of Oxford |
Parkinson's drug discovery |
Department of Psychiatry, University of Oxford |
Clinical trials, cohorts |
|
Department of Psychiatry, University of Oxford |
Experimental psychology and cognitive neuroscience, genetics & genomics, imaging |
|
ARUK Oxford Drug Discovery Institute, University of Oxford |
Drug discovery |
|
DeNDRoN / Oxford University Hospitals NHS Trust |
Clinical trials |
|
Ellen McCulloch |
Nuffield Department of Medicine, University of Oxford |
Clinical research nurse |
DeNDRoN / Oxford University Hospitals NHS Trust |
Clinical trials, pharmacology, service evaluation |
|
DeNDRoN / Oxford University Hospitals NHS Trust |
Lead research nurse manager |
|
Emma Murphy |
ARUK Oxford Drug Discovery Institute |
|
Oxford Centre for Human Brain Activity, University of Oxford |
Experimental psychology & cognitive neuroscience, imaging, genetics & genomics |
|
Members N-R |
|
|
Department of Psychiatry, University of Oxford |
Cellular and molecular biology, clinical trials, cohorts, epidemiology /cohort studies, genetics & genomics, neuropathology, pharmacology |
|
Department of Psychiatry, University of Oxford |
Computational methods, healthy ageing |
|
Department of Physiology, Anatomy and Genetics, University of Oxford |
Cellular and molecular biology |
|
Department of Psychiatry, University of Oxford |
ARUK Early Careers Representative Cellular biology, high-throughput screening |
|
Nuffield Department of Medicine, University of Oxford | Neuroscience, Molecular Biology, primary cell culture | |
Department of Life, Health & Chemical Sciences, Open University |
Neuroscience, histology, cell biology |
|
Department of Experimental Psychology, University of Oxford | Experimental psychology & cognitive neuroscience, imaging | |
Nuffield Department of Clinical Neurosciences, University of Oxford |
Transgenic models, blood & CSF analysis, cognitive tests, genetics, histopathology, immunohistochemistry molecular biology |
|
Nuffield Department of Clinical Neurosciences, University of Oxford |
Cohorts, experimental psychology & cognitive neuroscience, service evaluation |
|
Richard Priestley |
Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford |
Target validation and assay development |
Cynthia Prendergast |
Department of Pharmacology, University of Oxford |
Pharmacology |
Nuffield Department of Clinical Neurosciences, University of Oxford |
Biomarkers, neuropathology |
|
Department of Psychology, Oxford Brookes University |
Cognitive psychology |
|
Department of Psychiatry, University of Oxford |
Translational Neuroscience, animal models |
|
Department of Pharmacology, University of Oxford |
Blood & CSF analysis, clinical trials, epidemiology/cohort studies, genetics & genomics |
|
Target Discovery Institute, University of Oxford |
Translational Neuroscience, cellular & molecular biology |
|
Hazel Hall-Roberts |
ARUK Oxford Drug Discovery Institute, and the James Martin Stem Cell Facility, University of Oxford. |
Microglia, iPSc, cellular & molecular biology |
Department of Psychiatry, University of Oxford |
Project coordinator for the European Prevention of Alzheimer's Disease (EPAD) project |
|
Department of Physiology, Anatomy and Genetics, University of Oxford |
Phenotypes, high-throughput screens, iPSc, mass spectrometry |
|
Members S-Z |
|
|
Department of Physiology, Anatomy and Genetics, University of Oxford |
Bioinformatics |
|
Irene Sechi |
Target Discovery Institute, University of Oxford |
Target discovery |
Department of Psychiatry, University of Oxford |
Cohorts, imaging |
|
Department of Psychiatry, University of Oxford |
Blood based biomarkers |
|
Carolyn Sloan |
Nuffield Department of Clinical Neurosciences, University of Oxford |
Laboratory manager, Neuropathology department |
Department of Pharmacology, University of Oxford |
Pharmacology, imaging |
|
Thomas Smith |
ARUK Oxford Drug Discovery Institute |
ODDI - Neuroinflammation |
Department of Psychiatry, University of Oxford |
Genetics, MRI, neuroimaging |
|
Structural Genomics Consortium, Oxford University |
Crystallography, protein purification |
|
Nuffield Department of Clinical Neurosciences, University of Oxford |
Transgenic models, cellular & molecular biology, clinical trials |
|
*Francesco Tamagnini |
Department of Pharmacology, University of Reading |
Cellular biology, electrophysiology, tauopathy and amyloidopathy |
Department of Pharmacology, University of Reading |
Transgenic models, cellular and molecular biology, imaging, neuropathology |
|
Nuffield Department of Clinical Neurosciences, University of Oxford |
Cellular and molecular biology |
|
Nuffield Department of Clinical Neurosciences, University of Oxford |
Experimental psychology & cognitive neuroscience |
|
Department of Psychiatry, University of Oxford |
Neuroimaging, longitudinal epidemiological studies, cognition |
|
Nuffield Department of Clinical Neurosciences, University of Oxford |
Blood & CSF analysis, experimental psychology & cognitive neuroscience, imaging, genetics & genomics |
|
School of Psychology and Clinical Language Sciences, University of Reading |
Cognitive neuroscience, psychopathology | |
Nuffield Department of Clinical Neurosciences, University of Oxford |
FTD, genetics, stroke | |
Department of Physiology, Anatomy and Genetics, University of Oxford |
Transgenic models, translated mRNAs |
|
Department of Physiology, Anatomy and Genetics, University of Oxford. Oxford Parkinson's Disease Centre. |
Transgenic models, cellular and molecular biology, genetics & genomics |
|
Department of Pharmacology, University of Oxford |
Molecular biology |
|
Department of Physiology, Anatomy and Genetics and Department of Pharmacology, University of Oxford |
Bioinformatics |
|
Department of Psychiatry, University of Oxford |
Blood & CSF analysis |
|
Department of Physiology, Anatomy and Genetics and Department of Pharmacology, University of Oxford |
Cellular and molecular biology, electrophysiology (EEG), neuropathology, pharmacology |
|
Nuffield Department of Clinical Neurosciences, University of Oxford |
Clinical trials, experimental psychology & cognitive neuroscience |
|
School of Psychology & Clinical Language Sciences at the University of Reading |
Behaviour; nutrition & cognition |
|
Oxford Health NHS Foundation Trust |
Clinical care, neurodegeneration |
|
Department of Psychiatry, University of Oxford |
Informatics, large scale omics data to identify novel biomarkers |
|
|
|
|
Translational Neuroscience and Dementia Research Group, University of Oxford |
Translational Neuroscience, bioinformatics |
|
Nuffield Department of Clinical Neurosciences, University of Oxford |
Clinical neurology, neuroimaging, cognition |
|
School of Biological Sciences, University of Reading |
Professor in Systems Engineering and Neuroscience |
|
|
* = new member |
|